Home › Companies › Abbott Laboratories › 2025-2026
Compiled from SEC Form N-PX filings and Abbott Laboratories’s Form 8-K (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore Abbott Laboratories in the interactive database Compare manager voting policies
These tallies are Abbott Laboratories’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Nita Ahuja | 1,355,031,895 | 2,769,947 | 2,308,000 | -- | 177,761,396 | Majority: yes |
| Elect Director: Claire Babineaux-Fontenot | 1,355,031,167 | 2,886,973 | 2,191,702 | -- | 177,761,396 | Majority: yes |
| Elect Director: Sally E. Blount | 1,340,491,010 | 16,504,318 | 3,114,514 | -- | 177,761,396 | Majority: yes |
| Elect Director: Robert B. Ford | 1,281,298,501 | 72,599,833 | 6,211,508 | -- | 177,761,396 | Majority: yes |
| Elect Director: Paola Gonzalez | 1,350,598,638 | 6,179,509 | 331,695 | -- | 177,761,396 | Majority: yes |
| Elect Director: Michelle A. Kumbier | 1,346,291,350 | 11,453,399 | 2,365,093 | -- | 177,761,396 | Majority: yes |
| Elect Director: Darren W. McDew | 1,350,511,200 | 6,363,222 | 3,235,420 | -- | 177,761,396 | Majority: yes |
| Elect Director: Nancy McKinstry | 1,289,618,114 | 68,049,468 | 2,442,260 | -- | 177,761,396 | Majority: yes |
| Elect Director: Michael G. O'Grady | 1,325,498,060 | 32,189,526 | 2,422,256 | -- | 177,761,396 | Majority: yes |
| Elect Director: Michael F. Roman | 1,338,763,530 | 18,363,024 | 2,983,288 | -- | 177,761,396 | Majority: yes |
| Elect Director: Daniel J. Starks | 1,291,460,783 | 66,299,714 | 2,349,345 | -- | 177,761,396 | Majority: yes |
| Elect Director: John G. Stratton | 1,330,379,819 | 27,314,174 | 2,415,849 | -- | 177,761,396 | Majority: yes |
| (2) The shareholders ratified the appointment of Ernst & Young LLP as Abbott's auditors. | 1,502,083,607 | 33,333,515 | 2,454,116 | -- | 0 | Majority: yes |
| (3) The shareholders approved the compensation of Abbott's named executive officers listed in the proxy statement for the Annual Meeting, with 90.35 percent of the votes cast voting "For" the proposal. The shareholder vote is advisory and n | 1,228,911,693 | 126,315,146 | 4,883,003 | -- | 177,761,396 | Majority: yes |
| (4) The shareholders voted to approve the Abbott Laboratories 2026 Incentive Stock Program, with 95.82 percent of the votes cast voting "For" the proposal. | 1,303,349,739 | 52,296,340 | 4,463,763 | -- | 177,761,396 | Majority: yes |
| (5) The shareholders voted to approve the Abbott Laboratories 2026 Employee Stock Purchase Plan for Non-U.S. Employees, with 99.33 percent of the votes cast voting "For" the proposal. | 1,351,008,136 | 6,111,112 | 2,990,594 | -- | 177,761,396 | Majority: yes |
Source: Abbott Laboratories, Form 8-K — read the filing on EDGAR.
Each item below shows how the 1,701 asset managers that disclosed a Abbott Laboratories vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Abbott Laboratories’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Meeting held 2026-04-24.
Combines 47 wordings of this item as funds reported it.
91% Majority: yes · of votes cast
Abbott Laboratories’s own tally for this item (“(3) The shareholders approved the compensation of Abbott's named executive officers listed in the proxy statement for the Annual Meeting, with 90.35 percent of the votes cast voting "For" the proposal. The shareholder vo”): 1,228,911,693 for, 126,315,146 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
The 1,640 asset managers below cast 94% of the shares they voted on this item FOR (1,267,679,221 for, 86,800,799 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 201,377,981 | 610 | 26 | 0 | For |
| BlackRock | 123,484,052 | 11,476 | 0 | 0 | For |
| Capital Group | 114,665,557 | 0 | 3,824 | 0 | For |
| Capital Research Global Investors | 52,606,991 | 0 | 0 | 0 | For |
| State Street | 50,474,250 | 506,141 | 0 | 0 | For |
| Fidelity | 46,790,180 | 121,858 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 38,721,368 | 0 | 0 | 0 | For |
| T. Rowe Price | 30,690,399 | 44,748 | 0 | 0 | For |
| Wellington | 29,064,210 | 0 | 0 | 0 | For |
| Charles Schwab | 24,580,553 | 0 | 0 | 0 | For |
| Invesco | 22,977,817 | 0 | 0 | 0 | For |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 18,718,193 | 0 | 0 | 0 | For |
| Northern Trust | 17,495,915 | 133,801 | 0 | 0 | For |
| Janus Henderson | 16,541,690 | 5,000 | 0 | 0 | For |
| FRANKLIN ADVISERS INC | 14,423,362 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 14,216,191 | 0 | 0 | 0 | For |
| STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | 13,587,118 | 0 | 0 | 0 | For |
| JPMorgan | 13,257,018 | 0 | 0 | 0 | For |
| Nuveen | 12,918,802 | 5,336 | 0 | 0 | For |
| UBS | 0 | 12,694,755 | 0 | 0 | Against |
| AllianceBernstein | 11,296,552 | 0 | 0 | 0 | For |
| MFS | 10,291,379 | 0 | 0 | 0 | For |
| WELLS FARGO CLEARING SERVICES, LLC | 9,650,935 | 0 | 0 | 0 | For |
| Goldman Sachs | 9,061,219 | 0 | 0 | 0 | For |
| TIAA | 8,815,177 | 0 | 0 | 0 | For |
Showing the 25 largest of 1,640 asset managers. See all 1,640 in the interactive database.
Meeting held 2026-04-24.
Combines 14 wordings of this item as funds reported it.
99.5% Majority: yes · of votes cast
Abbott Laboratories’s own tally for this item (“(5) The shareholders voted to approve the Abbott Laboratories 2026 Employee Stock Purchase Plan for Non-U.S. Employees, with 99.33 percent of the votes cast voting "For" the proposal.”): 1,351,008,136 for, 6,111,112 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
The 276 asset managers below cast 99.9% of the shares they voted on this item FOR (540,919,419 for, 184,846 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 183,818,489 | 33 | 15 | 0 | For |
| Capital Group | 73,622,688 | 0 | 3,824 | 0 | For |
| BlackRock | 54,897,598 | 0 | 0 | 0 | For |
| Fidelity | 40,257,349 | 0 | 0 | 0 | For |
| State Street | 21,063,699 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 14,216,191 | 0 | 0 | 0 | For |
| JPMorgan | 13,169,439 | 0 | 0 | 0 | For |
| Charles Schwab | 10,424,827 | 0 | 0 | 0 | For |
| MFS | 10,291,379 | 0 | 0 | 0 | For |
| TIAA | 8,690,594 | 0 | 0 | 0 | For |
| T. Rowe Price | 8,214,126 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 7,743,260 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 7,311,255 | 0 | 0 | 0 | For |
| Invesco | 7,002,763 | 0 | 0 | 0 | For |
| First Trust | 5,452,707 | 0 | 0 | 0 | For |
| Dimensional | 5,050,375 | 0 | 0 | 0 | For |
| FRANKLIN MANAGED TRUST | 4,635,000 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,505,676 | 0 | 0 | 0 | For |
| Jackson National | 3,273,879 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,635,473 | 0 | 0 | 0 | For |
| GMO | 2,618,724 | 0 | 0 | 0 | For |
| DIAMOND HILL FUNDS | 2,524,497 | 0 | 0 | 0 | For |
| WisdomTree | 2,484,468 | 0 | 0 | 0 | For |
| Hartford | 2,089,446 | 0 | 0 | 0 | For |
| Nuveen | 1,795,644 | 0 | 0 | 0 | For |
Showing the 25 largest of 276 asset managers. See all 276 in the interactive database.
Meeting held 2026-04-24.
Combines 7 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Abbott Laboratories’s own tally for this item (“(4) The shareholders voted to approve the Abbott Laboratories 2026 Incentive Stock Program, with 95.82 percent of the votes cast voting "For" the proposal.”): 1,303,349,739 for, 52,296,340 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
The 263 asset managers below cast 99.7% of the shares they voted on this item FOR (539,027,593 for, 1,186,245 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 183,818,223 | 290 | 23 | 0 | For |
| Capital Group | 73,622,688 | 0 | 3,824 | 0 | For |
| BlackRock | 54,897,598 | 0 | 0 | 0 | For |
| Fidelity | 40,257,349 | 0 | 0 | 0 | For |
| State Street | 21,063,419 | 280 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 14,216,191 | 0 | 0 | 0 | For |
| JPMorgan | 13,169,439 | 0 | 0 | 0 | For |
| Charles Schwab | 10,424,827 | 0 | 0 | 0 | For |
| MFS | 10,291,379 | 0 | 0 | 0 | For |
| TIAA | 8,690,594 | 0 | 0 | 0 | For |
| T. Rowe Price | 8,214,126 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 7,743,260 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 7,311,255 | 0 | 0 | 0 | For |
| Invesco | 7,002,763 | 0 | 0 | 0 | For |
| First Trust | 5,452,707 | 0 | 0 | 0 | For |
| Dimensional | 5,050,375 | 0 | 0 | 0 | For |
| FRANKLIN MANAGED TRUST | 4,635,000 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,505,676 | 0 | 0 | 0 | For |
| Jackson National | 3,273,879 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,635,473 | 0 | 0 | 0 | For |
| GMO | 2,618,724 | 0 | 0 | 0 | For |
| DIAMOND HILL FUNDS | 2,524,497 | 0 | 0 | 0 | For |
| WisdomTree | 2,484,468 | 0 | 0 | 0 | For |
| Hartford | 2,089,446 | 0 | 0 | 0 | For |
| Nuveen | 1,795,644 | 0 | 0 | 0 | For |
Showing the 25 largest of 263 asset managers. See all 263 in the interactive database.
Meeting held 2026-04-24.
Combines 6 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Abbott Laboratories’s own tally for this item (“(2) The shareholders ratified the appointment of Ernst & Young LLP as Abbott's auditors.”): 1,502,083,607 for, 33,333,515 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
The 256 asset managers below cast 99.9% of the shares they voted on this item FOR (540,531,873 for, 39,585 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 183,818,348 | 180 | 10 | 0 | For |
| Capital Group | 73,622,688 | 0 | 0 | 0 | For |
| BlackRock | 54,897,598 | 0 | 0 | 0 | For |
| Fidelity | 40,257,349 | 0 | 0 | 0 | For |
| State Street | 21,063,419 | 280 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 14,216,191 | 0 | 0 | 0 | For |
| JPMorgan | 13,169,439 | 0 | 0 | 0 | For |
| Charles Schwab | 10,424,827 | 0 | 0 | 0 | For |
| MFS | 10,291,379 | 0 | 0 | 0 | For |
| TIAA | 8,690,594 | 0 | 0 | 0 | For |
| T. Rowe Price | 8,214,126 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 7,743,260 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 7,311,255 | 0 | 0 | 0 | For |
| Invesco | 7,002,763 | 0 | 0 | 0 | For |
| First Trust | 5,452,707 | 0 | 0 | 0 | For |
| Dimensional | 5,050,375 | 0 | 0 | 0 | For |
| FRANKLIN MANAGED TRUST | 4,635,000 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,505,676 | 0 | 0 | 0 | For |
| Jackson National | 3,273,879 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,635,473 | 0 | 0 | 0 | For |
| GMO | 2,618,724 | 0 | 0 | 0 | For |
| DIAMOND HILL FUNDS | 2,524,497 | 0 | 0 | 0 | For |
| WisdomTree | 2,484,468 | 0 | 0 | 0 | For |
| Hartford | 2,089,446 | 0 | 0 | 0 | For |
| Nuveen | 1,795,644 | 0 | 0 | 0 | For |
Showing the 25 largest of 256 asset managers. See all 256 in the interactive database.
Meeting held 2026-04-24.
Combines 10 wordings of this item as funds reported it.
99.7% Majority: yes · of votes cast
Abbott Laboratories’s own tally for this item (“Elect Director: Claire Babineaux-Fontenot”): 1,355,031,167 for, 2,886,973 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
The 251 asset managers below cast 99.9% of the shares they voted on this item FOR (540,520,558 for, 2,306 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 183,818,509 | 15 | 8 | 0 | For |
| Capital Group | 73,622,688 | 0 | 0 | 0 | For |
| BlackRock | 54,897,598 | 0 | 0 | 0 | For |
| Fidelity | 40,257,349 | 0 | 0 | 0 | For |
| State Street | 21,063,699 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 14,216,191 | 0 | 0 | 0 | For |
| JPMorgan | 13,169,439 | 0 | 0 | 0 | For |
| Charles Schwab | 10,424,827 | 0 | 0 | 0 | For |
| MFS | 10,291,379 | 0 | 0 | 0 | For |
| TIAA | 8,690,594 | 0 | 0 | 0 | For |
| T. Rowe Price | 8,214,126 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 7,743,260 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 7,311,255 | 0 | 0 | 0 | For |
| Invesco | 7,002,763 | 0 | 0 | 0 | For |
| First Trust | 5,452,707 | 0 | 0 | 0 | For |
| Dimensional | 5,050,375 | 0 | 0 | 0 | For |
| FRANKLIN MANAGED TRUST | 4,635,000 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,505,676 | 0 | 0 | 0 | For |
| Jackson National | 3,273,879 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,635,473 | 0 | 0 | 0 | For |
| GMO | 2,618,724 | 0 | 0 | 0 | For |
| DIAMOND HILL FUNDS | 2,524,497 | 0 | 0 | 0 | For |
| WisdomTree | 2,484,468 | 0 | 0 | 0 | For |
| Hartford | 2,089,446 | 0 | 0 | 0 | For |
| Nuveen | 1,795,644 | 0 | 0 | 0 | For |
Showing the 25 largest of 251 asset managers. See all 251 in the interactive database.
Meeting held 2026-04-24.
Combines 10 wordings of this item as funds reported it.
99.7% Majority: yes · of votes cast
Abbott Laboratories’s own tally for this item (“Elect Director: Nita Ahuja”): 1,355,031,895 for, 2,769,947 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
The 251 asset managers below cast 99.9% of the shares they voted on this item FOR (540,530,427 for, 2,305 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 183,818,509 | 14 | 2 | 0 | For |
| Capital Group | 73,622,688 | 0 | 0 | 0 | For |
| BlackRock | 54,897,598 | 0 | 0 | 0 | For |
| Fidelity | 40,257,349 | 0 | 0 | 0 | For |
| State Street | 21,063,699 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 14,216,191 | 0 | 0 | 0 | For |
| JPMorgan | 13,169,439 | 0 | 0 | 0 | For |
| Charles Schwab | 10,424,827 | 0 | 0 | 0 | For |
| MFS | 10,291,379 | 0 | 0 | 0 | For |
| TIAA | 8,690,594 | 0 | 0 | 0 | For |
| T. Rowe Price | 8,214,126 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 7,743,260 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 7,311,255 | 0 | 0 | 0 | For |
| Invesco | 7,002,763 | 0 | 0 | 0 | For |
| First Trust | 5,452,707 | 0 | 0 | 0 | For |
| Dimensional | 5,050,375 | 0 | 0 | 0 | For |
| FRANKLIN MANAGED TRUST | 4,635,000 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,505,676 | 0 | 0 | 0 | For |
| Jackson National | 3,273,879 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,635,473 | 0 | 0 | 0 | For |
| GMO | 2,618,724 | 0 | 0 | 0 | For |
| DIAMOND HILL FUNDS | 2,524,497 | 0 | 0 | 0 | For |
| WisdomTree | 2,484,468 | 0 | 0 | 0 | For |
| Hartford | 2,089,446 | 0 | 0 | 0 | For |
| Nuveen | 1,795,644 | 0 | 0 | 0 | For |
Showing the 25 largest of 251 asset managers. See all 251 in the interactive database.
Meeting held 2026-04-24.
Combines 10 wordings of this item as funds reported it.
99.5% Majority: yes · of votes cast
Abbott Laboratories’s own tally for this item (“Elect Director: Paola Gonzalez”): 1,350,598,638 for, 6,179,509 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
The 251 asset managers below cast 99.9% of the shares they voted on this item FOR (540,520,533 for, 2,324 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 183,818,484 | 33 | 18 | 0 | For |
| Capital Group | 73,622,688 | 0 | 0 | 0 | For |
| BlackRock | 54,897,598 | 0 | 0 | 0 | For |
| Fidelity | 40,257,349 | 0 | 0 | 0 | For |
| State Street | 21,063,699 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 14,216,191 | 0 | 0 | 0 | For |
| JPMorgan | 13,169,439 | 0 | 0 | 0 | For |
| Charles Schwab | 10,424,827 | 0 | 0 | 0 | For |
| MFS | 10,291,379 | 0 | 0 | 0 | For |
| TIAA | 8,690,594 | 0 | 0 | 0 | For |
| T. Rowe Price | 8,214,126 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 7,743,260 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 7,311,255 | 0 | 0 | 0 | For |
| Invesco | 7,002,763 | 0 | 0 | 0 | For |
| First Trust | 5,452,707 | 0 | 0 | 0 | For |
| Dimensional | 5,050,375 | 0 | 0 | 0 | For |
| FRANKLIN MANAGED TRUST | 4,635,000 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,505,676 | 0 | 0 | 0 | For |
| Jackson National | 3,273,879 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,635,473 | 0 | 0 | 0 | For |
| GMO | 2,618,724 | 0 | 0 | 0 | For |
| DIAMOND HILL FUNDS | 2,524,497 | 0 | 0 | 0 | For |
| WisdomTree | 2,484,468 | 0 | 0 | 0 | For |
| Hartford | 2,089,446 | 0 | 0 | 0 | For |
| Nuveen | 1,795,644 | 0 | 0 | 0 | For |
Showing the 25 largest of 251 asset managers. See all 251 in the interactive database.
Meeting held 2026-04-24.
Combines 10 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Abbott Laboratories’s own tally for this item (“Elect Director: Robert B. Ford”): 1,281,298,501 for, 72,599,833 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
The 251 asset managers below cast 99.7% of the shares they voted on this item FOR (539,024,822 for, 1,148,040 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 183,818,129 | 393 | 13 | 0 | For |
| Capital Group | 73,622,688 | 0 | 0 | 0 | For |
| BlackRock | 54,897,598 | 0 | 0 | 0 | For |
| Fidelity | 40,257,349 | 0 | 0 | 0 | For |
| State Street | 21,063,542 | 157 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 14,216,191 | 0 | 0 | 0 | For |
| JPMorgan | 13,169,439 | 0 | 0 | 0 | For |
| Charles Schwab | 10,424,827 | 0 | 0 | 0 | For |
| MFS | 10,291,379 | 0 | 0 | 0 | For |
| TIAA | 8,690,594 | 0 | 0 | 0 | For |
| T. Rowe Price | 8,214,126 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 7,743,260 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 7,311,255 | 0 | 0 | 0 | For |
| Invesco | 7,002,763 | 0 | 0 | 0 | For |
| First Trust | 5,452,707 | 0 | 0 | 0 | For |
| Dimensional | 5,050,375 | 0 | 0 | 0 | For |
| FRANKLIN MANAGED TRUST | 4,635,000 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,505,676 | 0 | 0 | 0 | For |
| Jackson National | 3,273,879 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,635,473 | 0 | 0 | 0 | For |
| GMO | 2,618,724 | 0 | 0 | 0 | For |
| DIAMOND HILL FUNDS | 2,524,497 | 0 | 0 | 0 | For |
| WisdomTree | 2,484,468 | 0 | 0 | 0 | For |
| Hartford | 2,089,446 | 0 | 0 | 0 | For |
| Nuveen | 1,795,644 | 0 | 0 | 0 | For |
Showing the 25 largest of 251 asset managers. See all 251 in the interactive database.
Meeting held 2026-04-24.
Combines 10 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Abbott Laboratories’s own tally for this item (“Elect Director: Sally E. Blount”): 1,340,491,010 for, 16,504,318 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
The 251 asset managers below cast 99.9% of the shares they voted on this item FOR (540,346,985 for, 185,744 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 183,818,429 | 91 | 17 | 0 | For |
| Capital Group | 73,622,688 | 0 | 0 | 0 | For |
| BlackRock | 54,897,598 | 0 | 0 | 0 | For |
| Fidelity | 40,257,349 | 0 | 0 | 0 | For |
| State Street | 21,063,419 | 280 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 14,216,191 | 0 | 0 | 0 | For |
| JPMorgan | 13,169,439 | 0 | 0 | 0 | For |
| Charles Schwab | 10,424,827 | 0 | 0 | 0 | For |
| MFS | 10,291,379 | 0 | 0 | 0 | For |
| TIAA | 8,690,594 | 0 | 0 | 0 | For |
| T. Rowe Price | 8,214,126 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 7,743,260 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 7,311,255 | 0 | 0 | 0 | For |
| Invesco | 7,002,763 | 0 | 0 | 0 | For |
| First Trust | 5,452,707 | 0 | 0 | 0 | For |
| Dimensional | 5,050,375 | 0 | 0 | 0 | For |
| FRANKLIN MANAGED TRUST | 4,635,000 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,505,676 | 0 | 0 | 0 | For |
| Jackson National | 3,273,879 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,635,473 | 0 | 0 | 0 | For |
| GMO | 2,618,724 | 0 | 0 | 0 | For |
| DIAMOND HILL FUNDS | 2,524,497 | 0 | 0 | 0 | For |
| WisdomTree | 2,484,468 | 0 | 0 | 0 | For |
| Hartford | 2,089,446 | 0 | 0 | 0 | For |
| Nuveen | 1,795,644 | 0 | 0 | 0 | For |
Showing the 25 largest of 251 asset managers. See all 251 in the interactive database.
Meeting held 2026-04-24.
Combines 9 wordings of this item as funds reported it.
99.1% Majority: yes · of votes cast
Abbott Laboratories’s own tally for this item (“Elect Director: Michelle A. Kumbier”): 1,346,291,350 for, 11,453,399 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
The 251 asset managers below cast 99.9% of the shares they voted on this item FOR (540,520,512 for, 2,352 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 183,818,463 | 61 | 13 | 0 | For |
| Capital Group | 73,622,688 | 0 | 0 | 0 | For |
| BlackRock | 54,897,598 | 0 | 0 | 0 | For |
| Fidelity | 40,257,349 | 0 | 0 | 0 | For |
| State Street | 21,063,699 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 14,216,191 | 0 | 0 | 0 | For |
| JPMorgan | 13,169,439 | 0 | 0 | 0 | For |
| Charles Schwab | 10,424,827 | 0 | 0 | 0 | For |
| MFS | 10,291,379 | 0 | 0 | 0 | For |
| TIAA | 8,690,594 | 0 | 0 | 0 | For |
| T. Rowe Price | 8,214,126 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 7,743,260 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 7,311,255 | 0 | 0 | 0 | For |
| Invesco | 7,002,763 | 0 | 0 | 0 | For |
| First Trust | 5,452,707 | 0 | 0 | 0 | For |
| Dimensional | 5,050,375 | 0 | 0 | 0 | For |
| FRANKLIN MANAGED TRUST | 4,635,000 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,505,676 | 0 | 0 | 0 | For |
| Jackson National | 3,273,879 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,635,473 | 0 | 0 | 0 | For |
| GMO | 2,618,724 | 0 | 0 | 0 | For |
| DIAMOND HILL FUNDS | 2,524,497 | 0 | 0 | 0 | For |
| WisdomTree | 2,484,468 | 0 | 0 | 0 | For |
| Hartford | 2,089,446 | 0 | 0 | 0 | For |
| Nuveen | 1,795,644 | 0 | 0 | 0 | For |
Showing the 25 largest of 251 asset managers. See all 251 in the interactive database.
Meeting held 2026-04-24.
Combines 10 wordings of this item as funds reported it.
99.5% Majority: yes · of votes cast
Abbott Laboratories’s own tally for this item (“Elect Director: Darren W. McDew”): 1,350,511,200 for, 6,363,222 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
The 251 asset managers below cast 99.9% of the shares they voted on this item FOR (540,500,791 for, 31,936 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 183,818,484 | 34 | 17 | 0 | For |
| Capital Group | 73,622,688 | 0 | 0 | 0 | For |
| BlackRock | 54,897,598 | 0 | 0 | 0 | For |
| Fidelity | 40,257,349 | 0 | 0 | 0 | For |
| State Street | 21,063,699 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 14,216,191 | 0 | 0 | 0 | For |
| JPMorgan | 13,169,439 | 0 | 0 | 0 | For |
| Charles Schwab | 10,424,827 | 0 | 0 | 0 | For |
| MFS | 10,291,379 | 0 | 0 | 0 | For |
| TIAA | 8,690,594 | 0 | 0 | 0 | For |
| T. Rowe Price | 8,214,126 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 7,743,260 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 7,311,255 | 0 | 0 | 0 | For |
| Invesco | 7,002,763 | 0 | 0 | 0 | For |
| First Trust | 5,452,707 | 0 | 0 | 0 | For |
| Dimensional | 5,050,375 | 0 | 0 | 0 | For |
| FRANKLIN MANAGED TRUST | 4,635,000 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,505,676 | 0 | 0 | 0 | For |
| Jackson National | 3,273,879 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,635,473 | 0 | 0 | 0 | For |
| GMO | 2,618,724 | 0 | 0 | 0 | For |
| DIAMOND HILL FUNDS | 2,524,497 | 0 | 0 | 0 | For |
| WisdomTree | 2,484,468 | 0 | 0 | 0 | For |
| Hartford | 2,089,446 | 0 | 0 | 0 | For |
| Nuveen | 1,795,644 | 0 | 0 | 0 | For |
Showing the 25 largest of 251 asset managers. See all 251 in the interactive database.
Meeting held 2026-04-24.
Combines 10 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Abbott Laboratories’s own tally for this item (“Elect Director: Nancy McKinstry”): 1,289,618,114 for, 68,049,468 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
The 251 asset managers below cast 99.9% of the shares they voted on this item FOR (540,206,990 for, 315,873 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 183,818,152 | 371 | 13 | 0 | For |
| Capital Group | 73,622,688 | 0 | 0 | 0 | For |
| BlackRock | 54,897,598 | 0 | 0 | 0 | For |
| Fidelity | 40,257,349 | 0 | 0 | 0 | For |
| State Street | 21,063,419 | 280 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 14,216,191 | 0 | 0 | 0 | For |
| JPMorgan | 13,169,439 | 0 | 0 | 0 | For |
| Charles Schwab | 10,424,827 | 0 | 0 | 0 | For |
| MFS | 10,291,379 | 0 | 0 | 0 | For |
| TIAA | 8,690,594 | 0 | 0 | 0 | For |
| T. Rowe Price | 8,214,126 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 7,743,260 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 7,311,255 | 0 | 0 | 0 | For |
| Invesco | 7,002,763 | 0 | 0 | 0 | For |
| First Trust | 5,452,707 | 0 | 0 | 0 | For |
| Dimensional | 5,050,375 | 0 | 0 | 0 | For |
| FRANKLIN MANAGED TRUST | 4,635,000 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,505,676 | 0 | 0 | 0 | For |
| Jackson National | 3,273,879 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,635,473 | 0 | 0 | 0 | For |
| GMO | 2,618,724 | 0 | 0 | 0 | For |
| DIAMOND HILL FUNDS | 2,524,497 | 0 | 0 | 0 | For |
| WisdomTree | 2,484,468 | 0 | 0 | 0 | For |
| Hartford | 2,089,446 | 0 | 0 | 0 | For |
| Nuveen | 1,795,644 | 0 | 0 | 0 | For |
Showing the 25 largest of 251 asset managers. See all 251 in the interactive database.
Meeting held 2026-04-24.
Combines 9 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Abbott Laboratories’s own tally for this item (“Elect Director: Michael G. O'Grady”): 1,325,498,060 for, 32,189,526 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
The 251 asset managers below cast 99.9% of the shares they voted on this item FOR (540,170,392 for, 352,473 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 183,818,343 | 182 | 13 | 0 | For |
| Capital Group | 73,622,688 | 0 | 0 | 0 | For |
| BlackRock | 54,897,598 | 0 | 0 | 0 | For |
| Fidelity | 40,257,349 | 0 | 0 | 0 | For |
| State Street | 21,063,699 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 14,216,191 | 0 | 0 | 0 | For |
| JPMorgan | 13,169,439 | 0 | 0 | 0 | For |
| Charles Schwab | 10,424,827 | 0 | 0 | 0 | For |
| MFS | 10,291,379 | 0 | 0 | 0 | For |
| TIAA | 8,690,594 | 0 | 0 | 0 | For |
| T. Rowe Price | 8,214,126 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 7,743,260 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 7,311,255 | 0 | 0 | 0 | For |
| Invesco | 7,002,763 | 0 | 0 | 0 | For |
| First Trust | 5,452,707 | 0 | 0 | 0 | For |
| Dimensional | 5,050,375 | 0 | 0 | 0 | For |
| FRANKLIN MANAGED TRUST | 4,635,000 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,505,676 | 0 | 0 | 0 | For |
| Jackson National | 3,273,879 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,635,473 | 0 | 0 | 0 | For |
| GMO | 2,618,724 | 0 | 0 | 0 | For |
| DIAMOND HILL FUNDS | 2,524,497 | 0 | 0 | 0 | For |
| WisdomTree | 2,484,468 | 0 | 0 | 0 | For |
| Hartford | 2,089,446 | 0 | 0 | 0 | For |
| Nuveen | 1,795,644 | 0 | 0 | 0 | For |
Showing the 25 largest of 251 asset managers. See all 251 in the interactive database.
Meeting held 2026-04-24.
Combines 9 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Abbott Laboratories’s own tally for this item (“Elect Director: Michael F. Roman”): 1,338,763,530 for, 18,363,024 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
The 251 asset managers below cast 99.9% of the shares they voted on this item FOR (540,520,467 for, 2,393 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 183,818,418 | 102 | 15 | 0 | For |
| Capital Group | 73,622,688 | 0 | 0 | 0 | For |
| BlackRock | 54,897,598 | 0 | 0 | 0 | For |
| Fidelity | 40,257,349 | 0 | 0 | 0 | For |
| State Street | 21,063,699 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 14,216,191 | 0 | 0 | 0 | For |
| JPMorgan | 13,169,439 | 0 | 0 | 0 | For |
| Charles Schwab | 10,424,827 | 0 | 0 | 0 | For |
| MFS | 10,291,379 | 0 | 0 | 0 | For |
| TIAA | 8,690,594 | 0 | 0 | 0 | For |
| T. Rowe Price | 8,214,126 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 7,743,260 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 7,311,255 | 0 | 0 | 0 | For |
| Invesco | 7,002,763 | 0 | 0 | 0 | For |
| First Trust | 5,452,707 | 0 | 0 | 0 | For |
| Dimensional | 5,050,375 | 0 | 0 | 0 | For |
| FRANKLIN MANAGED TRUST | 4,635,000 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,505,676 | 0 | 0 | 0 | For |
| Jackson National | 3,273,879 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,635,473 | 0 | 0 | 0 | For |
| GMO | 2,618,724 | 0 | 0 | 0 | For |
| DIAMOND HILL FUNDS | 2,524,497 | 0 | 0 | 0 | For |
| WisdomTree | 2,484,468 | 0 | 0 | 0 | For |
| Hartford | 2,089,446 | 0 | 0 | 0 | For |
| Nuveen | 1,795,644 | 0 | 0 | 0 | For |
Showing the 25 largest of 251 asset managers. See all 251 in the interactive database.
Meeting held 2026-04-24.
Combines 9 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Abbott Laboratories’s own tally for this item (“Elect Director: Daniel J. Starks”): 1,291,460,783 for, 66,299,714 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
The 251 asset managers below cast 99.8% of the shares they voted on this item FOR (539,840,401 for, 682,462 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 183,818,210 | 313 | 13 | 0 | For |
| Capital Group | 73,622,688 | 0 | 0 | 0 | For |
| BlackRock | 54,897,598 | 0 | 0 | 0 | For |
| Fidelity | 40,257,349 | 0 | 0 | 0 | For |
| State Street | 21,063,699 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 14,216,191 | 0 | 0 | 0 | For |
| JPMorgan | 13,169,439 | 0 | 0 | 0 | For |
| Charles Schwab | 10,424,827 | 0 | 0 | 0 | For |
| MFS | 10,291,379 | 0 | 0 | 0 | For |
| TIAA | 8,690,594 | 0 | 0 | 0 | For |
| T. Rowe Price | 8,214,126 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 7,743,260 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 7,311,255 | 0 | 0 | 0 | For |
| Invesco | 7,002,763 | 0 | 0 | 0 | For |
| First Trust | 5,452,707 | 0 | 0 | 0 | For |
| Dimensional | 5,050,375 | 0 | 0 | 0 | For |
| FRANKLIN MANAGED TRUST | 4,635,000 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,505,676 | 0 | 0 | 0 | For |
| Jackson National | 3,273,879 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,635,473 | 0 | 0 | 0 | For |
| GMO | 2,618,724 | 0 | 0 | 0 | For |
| DIAMOND HILL FUNDS | 2,524,497 | 0 | 0 | 0 | For |
| WisdomTree | 2,484,468 | 0 | 0 | 0 | For |
| Hartford | 2,089,446 | 0 | 0 | 0 | For |
| Nuveen | 1,795,644 | 0 | 0 | 0 | For |
Showing the 25 largest of 251 asset managers. See all 251 in the interactive database.
Meeting held 2026-04-24.
Combines 9 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Abbott Laboratories’s own tally for this item (“Elect Director: John G. Stratton”): 1,330,379,819 for, 27,314,174 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
The 251 asset managers below cast 99.9% of the shares they voted on this item FOR (540,399,821 for, 123,040 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 183,818,408 | 113 | 13 | 0 | For |
| Capital Group | 73,622,688 | 0 | 0 | 0 | For |
| BlackRock | 54,897,598 | 0 | 0 | 0 | For |
| Fidelity | 40,257,349 | 0 | 0 | 0 | For |
| State Street | 21,063,699 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 14,216,191 | 0 | 0 | 0 | For |
| JPMorgan | 13,169,439 | 0 | 0 | 0 | For |
| Charles Schwab | 10,424,827 | 0 | 0 | 0 | For |
| MFS | 10,291,379 | 0 | 0 | 0 | For |
| TIAA | 8,690,594 | 0 | 0 | 0 | For |
| T. Rowe Price | 8,214,126 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 7,743,260 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 7,311,255 | 0 | 0 | 0 | For |
| Invesco | 7,002,763 | 0 | 0 | 0 | For |
| First Trust | 5,452,707 | 0 | 0 | 0 | For |
| Dimensional | 5,050,375 | 0 | 0 | 0 | For |
| FRANKLIN MANAGED TRUST | 4,635,000 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,505,676 | 0 | 0 | 0 | For |
| Jackson National | 3,273,879 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,635,473 | 0 | 0 | 0 | For |
| GMO | 2,618,724 | 0 | 0 | 0 | For |
| DIAMOND HILL FUNDS | 2,524,497 | 0 | 0 | 0 | For |
| WisdomTree | 2,484,468 | 0 | 0 | 0 | For |
| Hartford | 2,089,446 | 0 | 0 | 0 | For |
| Nuveen | 1,795,644 | 0 | 0 | 0 | For |
Showing the 25 largest of 251 asset managers. See all 251 in the interactive database.
Meeting held 2026-04-24.
91% Majority: yes · of votes cast
Abbott Laboratories’s own tally for this item (“(3) The shareholders approved the compensation of Abbott's named executive officers listed in the proxy statement for the Annual Meeting, with 90.35 percent of the votes cast voting "For" the proposal. The shareholder vo”): 1,228,911,693 for, 126,315,146 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
The 34 asset managers below cast 85% of the shares they voted on this item FOR (209,362 for, 37,141 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BUTENSKY & COHEN FINANCIAL SECURITY, INC | 33,681 | 0 | 0 | 0 | For |
| LEAVELL INVESTMENT MANAGEMENT, INC. | 0 | 0 | 33,135 | 0 | Abstain |
| OLD SECOND NATIONAL BANK OF AURORA | 30,158 | 0 | 0 | 0 | For |
| PRENTISS SMITH & CO INC | 0 | 28,604 | 0 | 0 | Against |
| TEALWOOD ASSET MANAGEMENT INC | 26,123 | 0 | 0 | 0 | For |
| HARBOUR INVESTMENT MANAGEMENT LLC | 17,597 | 0 | 0 | 0 | For |
| COURIER CAPITAL LLC | 14,079 | 0 | 0 | 0 | For |
| Cove Private Wealth, LLC | 13,410 | 0 | 0 | 0 | For |
| Baker Avenue Asset Management, LP | 12,893 | 0 | 0 | 0 | For |
| EAGLE GLOBAL ADVISORS LLC | 12,067 | 0 | 0 | 0 | For |
| River Street Advisors LLC | 10,085 | 0 | 0 | 0 | For |
| WILLIAMSBURG INVESTMENT TRUST | 0 | 0 | 0 | 0 | Not Voted |
| WOODARD & CO ASSET MANAGEMENT GROUP INC /ADV | 0 | 8,273 | 0 | 0 | Against |
| Blue Edge Capital, LLC | 7,433 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST II | 6,516 | 0 | 0 | 0 | For |
| Ultimus Managers Trust | 4,840 | 0 | 0 | 0 | For |
| REXFORD CAPITAL INC | 4,626 | 0 | 0 | 0 | For |
| KTF INVESTMENTS, LLC | 3,000 | 0 | 0 | 0 | For |
| Wallace Capital Management Inc. | 2,900 | 0 | 0 | 0 | For |
| Evolutionary Tree Capital Management, LLC | 2,015 | 0 | 0 | 0 | For |
| Inlet Private Wealth, LLC | 1,605 | 0 | 0 | 0 | For |
| Ballew Advisors, Inc | 1,063 | 0 | 0 | 0 | For |
| PEDDOCK CAPITAL ADVISORS, LLC | 860 | 0 | 0 | 0 | For |
| McGowan Group Asset Management, Inc. | 743 | 0 | 0 | 0 | For |
| ESL Trust Services, LLC | 710 | 0 | 0 | 0 | For |
Showing the 25 largest of 34 asset managers. See all 34 in the interactive database.
Meeting held 2026-04-24.
99.5% Majority: yes · of votes cast
Abbott Laboratories’s own tally for this item (“(5) The shareholders voted to approve the Abbott Laboratories 2026 Employee Stock Purchase Plan for Non-U.S. Employees, with 99.33 percent of the votes cast voting "For" the proposal.”): 1,351,008,136 for, 6,111,112 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
The 14 asset managers below cast 98% of the shares they voted on this item FOR (795,066 for, 14,302 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Empower | 361,285 | 0 | 0 | 0 | For |
| America First Investment Advisors, LLC | 194,795 | 0 | 0 | 0 | For |
| Erste Asset Management GmbH | 145,232 | 0 | 0 | 0 | For |
| Vontobel Holding Ltd. | 27,800 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 22,661 | 0 | 0 | 0 | For |
| Maj Invest Holding A/S | 0 | 14,302 | 0 | 0 | Against |
| AGF Investments Trust | 11,701 | 0 | 0 | 0 | For |
| OARSMAN CAPITAL, INC. | 9,098 | 0 | 0 | 0 | For |
| Canopy Partners, LLC | 8,837 | 0 | 0 | 0 | For |
| VALUED ADVISERS TRUST | 5,797 | 0 | 0 | 0 | For |
| RWC Asset Management LLP | 2,142 | 0 | 0 | 0 | For |
| Sepio Capital, LP | 2,099 | 0 | 0 | 0 | For |
| WORMSER FRERES GESTION | 1,932 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund II | 1,687 | 0 | 0 | 0 | For |
Meeting held 2025-04-25 (outside the 2025-2026 season's 1 July to 30 June window; reported in this season's filings).
Combines 3 wordings of this item as funds reported it.
90% Majority: yes · of votes cast
Abbott Laboratories’s own tally for this item (“(3) The shareholders approved the compensation of Abbott's named executive officers listed in the proxy statement for the Annual Meeting, with 89.90 percent of the votes cast voting "For" the proposal. The shareholder vo”): 1,224,503,868 for, 130,699,445 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
The 10 asset managers below cast 85% of the shares they voted on this item FOR (510,220 for, 86,638 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| NORRIS PERNE & FRENCH LLP/MI | 224,522 | 0 | 0 | 0 | For |
| Investment Management Corp of Ontario | 126,025 | 0 | 0 | 0 | For |
| OSBORNE PARTNERS CAPITAL MANAGEMENT, LLC | 104,239 | 0 | 0 | 0 | For |
| OSSIAM | 0 | 81,730 | 0 | 0 | Against |
| GLENMEDE FUND INC | 34,541 | 0 | 0 | 0 | For |
| FIRST UNITED BANK & TRUST | 16,518 | 0 | 0 | 0 | For |
| PENSIOENFONDS RAIL & OV | 0 | 4,908 | 0 | 0 | Against |
| Philip James Wealth Mangement, LLC | 4,125 | 0 | 0 | 0 | For |
| ST. NICHOLAS PRIVATE ASSET MANAGEMENT, INC | 200 | 0 | 0 | 0 | For |
| Slow Capital, Inc. | 50 | 0 | 0 | 0 | For |
Meeting held 2026-04-24.
99.5% Majority: yes · of votes cast
Abbott Laboratories’s own tally for this item (“(5) The shareholders voted to approve the Abbott Laboratories 2026 Employee Stock Purchase Plan for Non-U.S. Employees, with 99.33 percent of the votes cast voting "For" the proposal.”): 1,351,008,136 for, 6,111,112 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
The 9 asset managers below cast 62% of the shares they voted on this item FOR (69,939 for, 42,635 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| LEAVELL INVESTMENT MANAGEMENT, INC. | 0 | 33,135 | 0 | 0 | Against |
| TEALWOOD ASSET MANAGEMENT INC | 26,123 | 0 | 0 | 0 | For |
| HARBOUR INVESTMENT MANAGEMENT LLC | 17,597 | 0 | 0 | 0 | For |
| Cove Private Wealth, LLC | 13,410 | 0 | 0 | 0 | For |
| WILLIAMSBURG INVESTMENT TRUST | 0 | 9,500 | 0 | 0 | Against |
| NORTHERN LIGHTS FUND TRUST II | 6,516 | 0 | 0 | 0 | For |
| Ultimus Managers Trust | 4,840 | 0 | 0 | 0 | For |
| McGowan Group Asset Management, Inc. | 743 | 0 | 0 | 0 | For |
| ESL Trust Services, LLC | 710 | 0 | 0 | 0 | For |
Meeting held 2026-04-24.
All nominees (reported as one line). These filers reported the election of directors as a single line covering every nominee. It is not attributed to any one director, and no share total is shown for it.
100% fund support · no official result
The 7 asset managers below cast 100% of the shares they voted on this item FOR.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| HARBOUR INVESTMENT MANAGEMENT LLC | 211,164 | 0 | 0 | 0 | For |
| TEALWOOD ASSET MANAGEMENT INC | 26,123 | 0 | 0 | 0 | For |
| WILLIAMSBURG INVESTMENT TRUST | 9,500 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST II | 6,516 | 0 | 0 | 0 | For |
| Ultimus Managers Trust | 4,840 | 0 | 0 | 0 | For |
| McGowan Group Asset Management, Inc. | 743 | 0 | 0 | 0 | For |
| ESL Trust Services, LLC | 710 | 0 | 0 | 0 | For |
Reported under meeting date 2026-02-24; no official results on file for that date.
Combines 2 wordings of this item as funds reported it.
100% fund support · no official result
The 4 asset managers below cast 100% of the shares they voted on this item FOR (929,757 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| SCHRODER INVESTMENT MANAGEMENT GROUP | 905,505 | 0 | 0 | 0 | For |
| MP63 FUND INC | 13,434 | 0 | 0 | 0 | For |
| Robertson Stephens Wealth Management, LLC | 7,177 | 0 | 0 | 0 | For |
| GLOBALT Investments LLC / GA | 3,641 | 0 | 0 | 0 | For |
Meeting held 2026-04-24.
Combines 2 wordings of this item as funds reported it.
91% Majority: yes · of votes cast
Abbott Laboratories’s own tally for this item (“(3) The shareholders approved the compensation of Abbott's named executive officers listed in the proxy statement for the Annual Meeting, with 90.35 percent of the votes cast voting "For" the proposal. The shareholder vo”): 1,228,911,693 for, 126,315,146 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
The 3 asset managers below cast 35% of the shares they voted on this item FOR (7,310 for, 13,488 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Cheviot Value Management, LLC | 0 | 13,488 | 0 | 0 | Against |
| Lincoln Financial | 7,154 | 0 | 0 | 0 | For |
| Blueprint Financial Advisors LLC | 156 | 0 | 0 | 0 | For |
Meeting held 2026-04-24.
91% Majority: yes · of votes cast
Abbott Laboratories’s own tally for this item (“(3) The shareholders approved the compensation of Abbott's named executive officers listed in the proxy statement for the Annual Meeting, with 90.35 percent of the votes cast voting "For" the proposal. The shareholder vo”): 1,228,911,693 for, 126,315,146 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
The 2 asset managers below cast 100% of the shares they voted on this item FOR (45,873 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Brookmont Capital Management | 35,089 | 0 | 0 | 0 | For |
| Members Trust Co | 10,784 | 0 | 0 | 0 | For |
Meeting held 2026-04-24.
100% fund support · no official result
The 2 asset managers below cast 100% of the shares they voted on this item FOR (11,847 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Members Trust Co | 10,784 | 0 | 0 | 0 | For |
| Ballew Advisors, Inc | 1,063 | 0 | 0 | 0 | For |
Ranked by the number of Abbott Laboratories shares each manager voted on the most widely held ballot item of the 2025-2026 meeting.
| # | Asset manager | Shares voted |
|---|---|---|
| 1 | Vanguard | 201,378,617 |
| 2 | BlackRock | 123,495,528 |
| 3 | Capital Group | 114,669,381 |
| 4 | Capital Research Global Investors | 52,606,991 |
| 5 | State Street | 50,980,391 |
| 6 | Fidelity | 46,912,038 |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 38,721,368 |
| 8 | T. Rowe Price | 30,735,147 |
| 9 | Wellington | 29,065,090 |
| 10 | Charles Schwab | 24,583,198 |
Shown as share counts, not percentages: no shares-outstanding figure has been matched to Abbott Laboratories for the 2025-2026 season, so there is no denominator to divide by.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At Abbott Laboratories's shareholder meeting held 2026-04-24, in the 2025-2026 proxy season, 1,701 asset managers reported how they voted in their SEC Form N-PX filings, covering 21,048 separate fund positions. Their filings are grouped here into 25 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Say on Pay - An Advisory Vote on the Approval of Executive Compensation — FOR was 91% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Abbott Laboratories's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission (filing date not recorded for this item).
Abbott Laboratories proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).